249 related articles for article (PubMed ID: 25185713)
1. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.
Staber PB; Zhang P; Ye M; Welner RS; Levantini E; Di Ruscio A; Ebralidze AK; Bach C; Zhang H; Zhang J; Vanura K; Delwel R; Yang H; Huang G; Tenen DG
Blood; 2014 Oct; 124(15):2391-9. PubMed ID: 25185713
[TBL] [Abstract][Full Text] [Related]
2. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
[TBL] [Abstract][Full Text] [Related]
3. Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
van der Kouwe E; Heller G; Czibere A; Pulikkan JA; Agreiter C; Castilla LH; Delwel R; Di Ruscio A; Ebralidze AK; Forte M; Grebien F; Heyes E; Kazianka L; Klinger J; Kornauth C; Le T; Lind K; Barbosa IAM; Pemovska T; Pichler A; Schmolke AS; Schweicker CM; Sill H; Sperr WR; Spittler A; Surapally S; Trinh BQ; Valent P; Vanura K; Welner RS; Zuber J; Tenen DG; Staber PB
Blood; 2021 Oct; 138(15):1345-1358. PubMed ID: 34010414
[TBL] [Abstract][Full Text] [Related]
4. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
[TBL] [Abstract][Full Text] [Related]
5. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract][Full Text] [Related]
6. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
[TBL] [Abstract][Full Text] [Related]
7. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
[TBL] [Abstract][Full Text] [Related]
9. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
11. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
12. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
14. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
[TBL] [Abstract][Full Text] [Related]
15. Definition of a small core transcriptional circuit regulated by AML1-ETO.
Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW
Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982
[TBL] [Abstract][Full Text] [Related]
16. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
[TBL] [Abstract][Full Text] [Related]
17. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
Dahl R; Simon MC
Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
[TBL] [Abstract][Full Text] [Related]
18. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
19. Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells.
Staber PB; Zhang P; Ye M; Welner RS; Nombela-Arrieta C; Bach C; Kerenyi M; Bartholdy BA; Zhang H; Alberich-Jordà M; Lee S; Yang H; Ng F; Zhang J; Leddin M; Silberstein LE; Hoefler G; Orkin SH; Göttgens B; Rosenbauer F; Huang G; Tenen DG
Mol Cell; 2013 Mar; 49(5):934-46. PubMed ID: 23395001
[TBL] [Abstract][Full Text] [Related]
20. The RUNX1-PU.1 axis in the control of hematopoiesis.
Imperato MR; Cauchy P; Obier N; Bonifer C
Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]